← Leaderboards
Robert J Deschenes
University Of Iowa
$5,231,929
Attributed
$5,649,173
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $642.7K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$5,649,173 · 5
By mechanism
R01$5,238,048 · 4
R21$411,125 · 1
Top collaborators
- Brian S J Blagg2 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Gulab Zode$8,352,014
- Val C Sheffield$29,509,881
- Michael G Anderson$5,875,752
- Keith G Avin$1,075,466
- Susan L Roman$37,674
Others in their field
Top investigators on “Mutant”
- Kc Kent Lloyd · University Of California At Davis$103,993,616
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Bruce A Beutler · Ut Southwestern Medical Center$34,438,453
- Oscar A. Carretero · Henry Ford Health System$33,594,856
- Stuart H Orkin · Children'S Hospital Boston$33,454,343
- Tracy T Batchelor · Dana-Farber Cancer Inst$31,851,614
Research focus
MutantMembrane ProteinsProteinsBaseMutationTransferaseProtein TransportPalmitatesSignal TransductionPalmitoylationMalignant NeoplasmsPlayMolecularModificationFamilyMemberProtein FamilyMembraneTraffickingVesicleCell MembraneLipidsIncidenceComplex
Grant awards (25)
Grp94-selective inhibitors to treat heredity glaucoma$416,063
R01 · FY2017 · EY · contact PI
Protein Palmitoylation and the Etiology of X-Linked Intellectual Disabilities$186,875
R21 · FY2017 · NS · contact PI
Grp94-selective inhibitors to treat heredity glaucoma$418,426
R01 · FY2016 · EY · contact PI
Protein Palmitoylation and the Etiology of X-Linked Intellectual Disabilities$224,250
R21 · FY2016 · NS · contact PI
Endomembrane Targeting and Signaling of RAS Proteins$273,742
R01 · FY2011 · GM · contact PI
Endomembrane Targeting and Signaling of RAS Proteins$276,507
R01 · FY2010 · GM · contact PI
Structural Changes and the Function of Ras Oncogenes$209,823
R01 · FY2010 · CA · contact PI
Endomembrane Targeting and Signaling of RAS Proteins$279,300
R01 · FY2009 · GM · contact PI
Structural Changes and the Function of Ras Oncogenes$209,823
R01 · FY2009 · CA · contact PI
Endomembrane Targeting and Signaling of RAS Proteins$242,253
R01 · FY2008 · GM · contact PI
Structural Changes and the Function of Ras Oncogenes$216,247
R01 · FY2008 · CA · contact PI
Endomembrane Targeting and Signaling of RAS Proteins$44,243
R01 · FY2008 · GM · contact PI
Structural Changes and the Function of Ras Oncogenes$246,547
R01 · FY2007 · CA · contact PI
Regulation of eucaryotic histidine kinases$262,971
R01 · FY2006 · GM · contact PI
Structural Changes and the Function of Ras Oncogenes$222,705
R01 · FY2006 · CA · contact PI
Regulation of eucaryotic histidine kinases$269,300
R01 · FY2005 · GM
Regulation of eucaryotic histidine kinases$14,635
R01 · FY2005 · GM
STRUCTURAL CHANGES AND THE FUNCTION OF RAS ONCOGENES$220,538
R01 · FY2004 · CA
Regulation of eucaryotic histidine kinases$141,600
R01 · FY2004 · GM
Regulation of eucaryotic histidine kinases$123,900
R01 · FY2004 · GM
Regulation of eukaryotic histidine kinases$288,000
R01 · FY2003 · GM
STRUCTURAL CHANGES AND THE FUNCTION OF RAS ONCOGENES$233,000
R01 · FY2003 · CA
STRUCTURAL CHANGES AND THE FUNCTION OF RAS ONCOGENES$209,475
R01 · FY2002 · CA
STRUCTURAL CHANGES AND THE FUNCTION OF RAS ONCOGENES$209,475
R01 · FY2001 · CA
STRUCTURAL CHANGES AND THE FUNCTION OF RAS ONCOGENES$209,475
R01 · FY2000 · CA